ARC-18 Improved Motor Performance Through Inhibiting ACLY-Mediated Smad2/3 Acetylation in a Model of Duchenne Muscular Dystrophy. [PDF]
Chen C +9 more
europepmc +1 more source
Management of adrenal insufficiency risk after long-term systemic glucocorticoid therapy in Duchenne muscular dystrophy: Clinical practice recommendations [PDF]
Bowden, Sasigarn A +3 more
core +1 more source
Exploring lncRNA-Mediated Mechanisms in Muscle Regulation and Their Implications for Duchenne Muscular Dystrophy. [PDF]
Gorji AE +6 more
europepmc +1 more source
Is dystrophin immunogenicity a barrier to advancing gene therapy for Duchenne muscular dystrophy? [PDF]
Górecki DC, Kalinski P, Pomeroy J.
europepmc +1 more source
Identifying kinematic biomarkers of the dystrophic phenotype in a zebrafish model of Duchenne muscular dystrophy. [PDF]
Widrick JJ +8 more
europepmc +1 more source
DWORF expression is reduced in a large animal model of Duchenne muscular dystrophy.
Gibson AM +12 more
europepmc +1 more source
Duvyzat (givinostat): a new hope for Duchenne muscular dystrophy patients. [PDF]
Syed N +5 more
europepmc +1 more source
Fully personalized modelling of Duchenne Muscular Dystrophy ambulation. [PDF]
Applebaum V +11 more
europepmc +1 more source
Acute Gastric Dilatation in Duchenne Muscular Dystrophy: A Case Report. [PDF]
Ramírez-Guerra YR +3 more
europepmc +1 more source
Complexities of care in a pediatric patient with epidermolysis bullosa acquisita and duchenne muscular dystrophy: a case report. [PDF]
Al-Shami K +7 more
europepmc +1 more source

